Concepedia

David Cerna

DC

17

Publications

1.2K

Citations

16

H-Index

2004

Active since

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

Science Applications International Corporation (United States)

National Institutes of Health

Molecular Oncology (United States)

David Cerna is an author at National Cancer Institute specializing in cell biology, medicine, and oncology.

Top concepts

Publications per year

2004–2021

17

Publications

17

Enhancement of <i>in vitro</i> and <i>in vivo</i> tumor cell radiosensitivity by valproic acid

Kevin Camphausen, David Cerna, Tamalee Scott et al. · International Journal of Cancer · 2004 · 191 citations · Full text

, , +18

PX‐478, an inhibitor of hypoxia‐inducible factor‐1α, enhances radiosensitivity of prostate carcinoma cells

Sanjeewani T. Palayoor, James B. Mitchell, David Cerna et al. · International Journal of Cancer · 2008 · 126 citations · Full text

, , +17

<i>In vitro</i> and <i>In vivo</i> Radiosensitization Induced by the DNA Methylating Agent Temozolomide

Whoon Jong Kil, David Cerna, William Burgan et al. · Clinical Cancer Research · 2008 · 109 citations

Enhancement of <i>In vitro</i> and <i>In vivo</i> Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine

Hideaki Dote, David Cerna, William Burgan et al. · Clinical Cancer Research · 2005 · 108 citations · Full text

, , +19

Postradiation Sensitization of the Histone Deacetylase Inhibitor Valproic Acid

Prakash Chinnaiyan, David Cerna, William Burgan et al. · Clinical Cancer Research · 2008 · 102 citations · Full text

Rows per page

1–5 of 17